Teri F. Willey
Managing Director @ IU Ventures
Cold Spring Harbor, United States
Teri F. Willey is a funding round investor at IU Ventures in Cold Spring Harbor focused on Biotechnology and Therapeutics. Teri F. Willey is the Managing Director at IU Ventures. Teri F. Willey attended University of Idaho.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Teri F. Willey invests in
Stages Teri F. Willey invests in
Countries Teri F. Willey invests in
Investment Focus
Industry
- Biotechnology 3 (50%)
- Therapeutics 2 (33%)
- Apps 1 (17%)
- SaaS 1 (17%)
- Legal 1 (17%)
Stage
- Funding Round 2 (33%)
- Seed 1 (17%)
- Series B 1 (17%)
- Convertible Note 1 (17%)
- Venture - Series Unknown 1 (17%)
Country
- United States 3 (50%)
- Canada 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
SeraGene Therapeutics
|
SeraGene Therapeutics is a biotechnology company that offers treatment for coagulation disorders through nanomedicine technologies and RNA. | Seed / Nov 19, 2025 | |
Confluence Pharmaceuticals
|
Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders. The company's current focus is advancing a novel drug discovery that improves social and communication impairments for individuals with Autism Spectrum Disorders and Fragile X Syndrome. | $200K / Venture - Series Unknown / Jun 17, 2022 | |
|
Confluence Pharmaceuticals
|
Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders. The company's current focus is advancing a novel drug discovery that improves social and communication impairments for individuals with Autism Spectrum Disorders and Fragile X Syndrome. | $100K / Dec 02, 2020 | |
Rubicon Genomics
|
Rubicon Genomics was founded in 2000 by two University of Michigan faculty members, Dr. John Langmore and Dr. Vladimir Makarov, who wanted to advance the translation of human genetics “laboratory knowledge” into practical medicine applications. The founders also decided to maintain the company’s roots in Michigan with a commitment to supporting theMichigan economy.Today, Rubicon Genomics is a privately held company located in Ann Arbor, Michigan and employs 20 administrative and technical staff. Our innovative products combined with our strategic partnerships have established the company as a leader in pre-analytical amplification technologies that "break the sample barriers" for our customers. Rubicon sells its products into the research and commercial markets directly and through distributors | $3.5M / Series B | |
|
Confluence Pharmaceuticals
|
Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders. The company's current focus is advancing a novel drug discovery that improves social and communication impairments for individuals with Autism Spectrum Disorders and Fragile X Syndrome. | $100K / Convertible Note | |
Doxly
|
Doxly develops transaction-management software for law firms. It was built with one simple vision: transform the archaic, chaotic process of managing legal transactions into a streamlined, efficient process. Built by lawyers, for lawyers, the Doxly platform exists to remove frustrations inherent in legal transactions. Doxly helps lawyers deliverbetter client experiences while building stronger practices. Doxly began operation in 2016. It has its headquarters in Indianapolis in Indiana. | $250K |
Co-Investors
About IU Ventures
IU Ventures is affiliated with Indiana University focusing on assisting IU students, faculty, staff, and alums in new venture opportunities.
IU Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jonathan Barada
Vice President - Engagement
|
|||
|
Teri F. Willey
Managing Director
|
|||
Adam Sobol
Shoebox Fund Investment Committee Member
|
|||
Jason Wadler
Member/IU Angels
|
|||
Ken Green
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Teri F. Willey invest in?
Teri F. Willey invests primarily in Biotechnology, Therapeutics and Apps startups, most often at Funding Round and Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Teri F. Willey last invest?
The most recent investment recorded for Teri F. Willey closed in Nov 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
